

Written by Kerri Rachelle, PhD(c), RDN, CSSD, FMP-AC
Founder & CEO, REV0lution | Doctor of Integrative & Natural Medicine Candidate
An autoimmune disease develops when misdirected immune activity targets the body’s own cells or tissues. Symptoms, testing and treatment depend on which immune pathways and organs are involved, and no single blood test can diagnose every autoimmune condition.
Autoimmune disease reflects a loss of immune tolerance—not simply an immune system that is “too strong.”
Symptoms may involve one organ or several body systems and frequently overlap with non-autoimmune conditions.
Genetics influence susceptibility, while infections, hormones, smoking, environmental exposures, stress physiology and other factors may affect disease development.
A positive antibody test does not automatically establish a diagnosis, and a negative result does not exclude every autoimmune disease.
Medication, nutrition, sleep, movement, stress support and other individualized care can work together.
The immune system protects the body by recognizing organisms, damaged cells and other substances that may pose a threat. It also needs to recognize the body’s own tissues and leave them unharmed. This ability is called immune tolerance.
Autoimmune disease develops when tolerance breaks down and immune cells, antibodies or inflammatory pathways begin targeting the body’s own structures.
The affected target determines how the disease may appear. Hashimoto’s disease primarily affects the thyroid. Type 1 diabetes targets insulin-producing cells in the pancreas. Multiple sclerosis damages structures within the central nervous system. Rheumatoid arthritis primarily affects joints, while lupus may involve the skin, joints, kidneys, blood vessels, lungs, nervous system and other organs.
Autoimmunity is therefore not one disease. It describes a broad category of conditions with different symptoms, diagnostic criteria and treatments.
Autoimmune activity and diagnosed autoimmune disease are related, but they are not interchangeable.
A person may have an autoantibody without having symptoms, tissue injury or a diagnosable autoimmune condition. Some autoantibodies can appear temporarily following an infection, occur with certain medications or be found in otherwise healthy people.
Autoimmune disease requires a larger clinical picture. Physicians consider symptoms, physical findings, laboratory results, imaging, tissue changes and established diagnostic criteria. The importance of any antibody depends on which antibody was measured, its concentration or pattern, the person’s symptoms and the condition being investigated.
An abnormal result deserves interpretation. It should not automatically become a diagnosis.
Autoimmune conditions may be organ-specific or systemic.
Common examples include:
Hashimoto’s disease
Graves’ disease
Rheumatoid arthritis
Systemic lupus erythematosus
Sjögren’s disease
Multiple sclerosis
Type 1 diabetes
Celiac disease
Crohn’s disease
Ulcerative colitis
Psoriasis and psoriatic arthritis
Ankylosing spondylitis
Autoimmune hepatitis
Primary biliary cholangitis
Vitiligo
Alopecia areata
Myasthenia gravis
Systemic sclerosis
Pernicious anemia
Some of these conditions primarily damage one organ. Others can change over time or involve multiple systems, which is one reason diagnosis may take longer than patients expect.
There is no universal set of early autoimmune symptoms. Possible symptoms depend on the tissues involved and may include:
Persistent or disproportionate fatigue
Joint pain, stiffness or swelling
Muscle weakness
Unexplained rashes or sun sensitivity
Dry eyes or dry mouth
Numbness, tingling or neurological changes
Digestive symptoms
Unexplained fevers
Swollen glands
Hair loss
Temperature intolerance
Changes in weight or appetite
Recurrent mouth or nasal sores
Color changes in the fingers or toes
Menstrual or fertility changes
Brain fog or difficulty concentrating
These symptoms are real, but they are not specific to autoimmunity. Fatigue may also occur with iron deficiency, thyroid dysfunction, inadequate energy intake, sleep apnea, infection, medication effects, perimenopause, depression, blood-sugar dysregulation and many other conditions.
That is why a symptom checklist cannot diagnose autoimmune disease. It can indicate that a more complete evaluation is warranted.
If fatigue is one of your primary concerns, begin with Why Am I Always Tired?.
Many autoimmune diseases disproportionately affect women, although the degree varies by condition. Lupus, Sjögren’s disease and autoimmune thyroid diseases demonstrate particularly strong female predominance.
There is no single explanation. Sex hormones influence immune-cell activity, and the X chromosome contains many genes involved in immune regulation. Differences in X-chromosome inactivation, pregnancy-related immune changes, fetal microchimerism, microbiome patterns, environmental exposures and diagnostic experiences are also being investigated.
This does not mean that autoimmunity is simply a hormonal problem. Men develop autoimmune diseases as well, and some conditions demonstrate different severity or manifestations between sexes.
Women also deserve better than having persistent fatigue, pain, digestive symptoms or cognitive changes dismissed as stress or aging. At the same time, not every symptom in a woman is autoimmune. Appropriate evaluation protects patients from both dismissal and overdiagnosis.
Autoimmune disease usually develops through an interaction among genetic susceptibility, immune regulation and environmental influences. A person may inherit a greater likelihood of developing a condition without ever developing the disease.
Variations in human leukocyte antigen genes and other immune-regulating genes can affect how antigens are presented to the immune system and how tolerance is maintained.
Certain HLA patterns are strongly associated with particular conditions. HLA-DQ2 and HLA-DQ8 are associated with celiac disease, while HLA-B27 is associated with ankylosing spondylitis and other forms of spondyloarthritis.
These genes influence risk; they do not guarantee an outcome. Family members who share susceptibility may still experience very different health trajectories.
Some infections can activate inflammatory pathways, disrupt tissue barriers or produce proteins that resemble human proteins. These processes may contribute to molecular mimicry, bystander activation or loss of immune tolerance.
The relationship is most convincing in certain specific contexts. Epstein–Barr virus, for example, has been strongly linked with the development of multiple sclerosis. Other proposed infection–autoimmune relationships remain less established.
Finding evidence of a previous infection does not prove that it is currently driving symptoms, and repeatedly treating historical exposure is not automatically appropriate.
The gut microbiome, intestinal barrier and gut-associated immune system can affect inflammatory signaling and immune tolerance. Dysbiosis and increased intestinal permeability have been observed across several autoimmune diseases.
The relationship may operate in both directions. Gut changes may contribute to immune dysregulation, while autoimmune inflammation, altered motility, dietary restriction and medication may change the gastrointestinal environment.
Gut health should be investigated when the symptoms and history support it, but it should not become a universal explanation for every autoimmune condition.
Stress-related disorders have been associated with a higher subsequent incidence of autoimmune disease in large observational studies. Stress can also influence sleep, immune signaling, blood sugar, eating patterns, pain perception and symptom intensity.
This does not mean a patient created her illness through her thoughts, emotions or inability to remain calm. Trauma and prolonged stress can leave physiological effects that deserve compassionate support.
Nervous-system regulation, counseling, restorative practices and protection of sleep may help create a more supportive internal environment. They remain components of care rather than replacements for medical treatment.
Smoking is a well-established risk factor for rheumatoid arthritis and can worsen several immune-mediated conditions. Occupational silica and certain dust exposures have also been associated with connective-tissue autoimmune disease.
Researchers are examining possible relationships involving solvents, air pollution, pesticides, endocrine-disrupting chemicals and other environmental exposures. The strength of evidence varies, and detecting a chemical does not prove it caused an individual’s disease.
Reducing avoidable exposure is reasonable. Living in fear of an impossible “toxin-free” environment is not healing.
No single food causes every autoimmune disease.
Celiac disease is the important exception in which gluten is the established environmental trigger in a genetically susceptible person. Other food-related responses are much more individualized.
A dietary pattern dominated by ultra-processed foods may provide less fiber, fewer micronutrients and a less supportive environment for metabolic and gut health. However, that does not mean a patient caused her autoimmune illness by eating the wrong food.
Nutrition can still influence energy, muscle, digestive function, metabolic health, nutrient status and quality of life. Some people also identify foods that meaningfully affect symptoms.
REV0lution recommends beginning with adequate nourishment, recognizable foods and a nutritionally complete meal structure. Restriction should answer a specific question and include a plan for nutritional replacement and reintroduction whenever appropriate.
Diagnosis begins with the clinical story.
A clinician may ask when symptoms began, which organs appear affected, whether symptoms come and go, what medications are being used, whether autoimmune disease runs in the family and whether there have been infections, pregnancies or relevant environmental exposures.
Testing then depends on the suspected condition. Evaluation may include:
Complete blood count
Metabolic and liver testing
Urinalysis
Thyroid testing
Iron, vitamin B12 or other nutrient markers
Erythrocyte sedimentation rate or C-reactive protein
Antinuclear antibodies
Rheumatoid factor and anti-CCP antibodies
Thyroid peroxidase and thyroglobulin antibodies
Celiac serology
Disease-specific autoantibodies
Complement proteins
Imaging
Nerve testing
Endoscopy
Tissue biopsy
A broad commercial “autoimmune panel” without a clear clinical question can create confusing results. Testing should be selected according to symptoms and interpreted in the context of the whole person.
Learn more about appropriate test selection in Functional Medicine Lab Testing.
No. Antinuclear antibodies may be present in lupus and other connective-tissue autoimmune diseases, but they can also occur in people without autoimmune disease.
The clinical meaning depends on the titer, staining pattern, testing method, symptoms and additional antibodies. An isolated positive ANA should not be used to diagnose lupus or explain every symptom.
At the same time, a positive result should not be dismissed when the symptoms and examination suggest autoimmune disease. It is one piece of a larger evaluation.
Yes. Some autoimmune diseases are considered seronegative when expected antibodies are not detected. Antibodies may also appear later, fluctuate, be affected by treatment or remain below the sensitivity of a particular assay.
This is another reason diagnosis cannot be reduced to a single laboratory result. Symptoms, examination, imaging, pathology and disease-specific criteria may remain important.
“Your test was negative” and “nothing is wrong” are not the same conclusion.
Treatment depends on the disease, the organs involved, the severity of inflammation and the degree of existing tissue damage.
Medications may replace something the damaged organ can no longer produce, as insulin does in type 1 diabetes and thyroid hormone does in hypothyroidism. Other medications reduce inflammation, modify immune activity, protect an organ, relieve symptoms or prevent progression and permanent damage.
Options may include corticosteroids, conventional disease-modifying medications, biologic therapies, targeted small molecules, intravenous immunoglobulin and other disease-specific treatments.
These therapies have potential risks, but they can also preserve mobility, protect organs and save lives. A functional approach should never frighten a patient away from necessary medication or specialist care.
The strongest model combines appropriate diagnosis and medical treatment with nutrition, sleep, movement, stress support and attention to the person’s daily life. Read more about how these models can work together in Functional Medicine vs. Conventional Medicine.
Nutrition cannot guarantee remission, but it can change the physiological environment in which a patient lives and heals.
Support may include:
Adequate energy intake
Meaningful real-food protein
Whole plants and fiber as tolerated
Individualized whole-food carbohydrates
Naturally occurring fats and omega-3-rich foods
Identification and correction of nutrient deficiencies
Support for bowel regularity and digestive function
Stable meal patterns
Appropriate hydration
Strength and aerobic movement matched to capacity
Restorative sleep
Stress-response and trauma-informed support
Reduced smoking and excessive alcohol exposure
Someone experiencing fatigue or an autoimmune flare may require more recovery and a different exercise dose. Pushing through exhaustion is not always resilience. Likewise, chronic under-eating can further compromise muscle, bone, hormone and immune health.
Supplements may be useful when there is a documented deficiency or defined clinical purpose. Iodine, selenium, vitamin D, iron and other nutrients should not be taken in high amounts simply because they appear on an “autoimmune protocol.”
REV0lution’s Registered Dietitians help patients build adequate, individualized nutrition alongside their medical care.
Some autoimmune diseases can enter clinical remission, and disease activity may sometimes remain low for extended periods. What remission means depends on the condition and may include symptom improvement, normalized disease markers, reduced medication requirements or absence of new tissue damage.
The word “reversed” is often used too casually. Once pancreatic beta cells, thyroid tissue, nerves or another structure have been significantly damaged, lowering immune activity does not necessarily restore what has been lost.
That does not eliminate hope. Earlier diagnosis, appropriate treatment and supportive lifestyle care can substantially change how someone feels and functions. The meaningful goal is not an impressive label. It is less disease activity, better function, protected organs, restored nourishment and a life that is no longer organized entirely around illness.
Medication should only be changed with the prescribing clinician.
Seek prompt medical evaluation for symptoms such as:
New weakness, loss of coordination or significant numbness
Sudden vision changes
Chest pain or difficulty breathing
Blood in the stool or black stool
Severe abdominal pain
Significant joint swelling with fever
Yellowing of the skin or eyes
Fainting or severe dehydration
Confusion or sudden neurological changes
Rapidly worsening symptoms
Persistent fatigue, pain, rashes, bowel changes or other unexplained symptoms also deserve evaluation even when they are not an emergency.
Autoimmune disease develops when immune tolerance breaks down and immune activity becomes directed toward the body’s own tissues. Genetics create susceptibility, while infections, hormones, environmental exposures, gut function, stress physiology and other influences may shape whether and how disease develops.
Diagnosis requires more than a symptom list or one antibody result. Treatment may include medication, nutrition, movement, sleep, digestive support and stress regulation—each selected for a clear reason.
Patients deserve care that protects them from disease progression while also helping them build the strongest foundation possible for healing, function and quality of life.
Medical Disclaimer: This article is for general educational and informational purposes only and does not provide individualized medical or nutrition advice. It is not intended to diagnose, treat, cure, or prevent disease or replace care from a qualified healthcare professional. Do not change your medications, supplements, diet, fasting schedule, or healthcare plan based solely on this content. [Read the full Medical Disclaimer and Terms & Conditions.]
Possible early symptoms include persistent fatigue, joint pain, rashes, digestive changes, dry eyes or mouth, numbness, weakness and unexplained fevers. These symptoms overlap with many other conditions, so they cannot diagnose autoimmunity by themselves.
Autoimmune thyroid diseases, including Hashimoto’s disease and Graves’ disease, are among the most common. Prevalence varies by population, sex and how conditions are classified.
Symptoms may appear suddenly, but immune susceptibility and biological changes may have been developing for months or years. Infections, pregnancy, major stress or other exposures sometimes precede symptom onset without necessarily being the single cause.
No. A positive ANA can support further evaluation when lupus is clinically suspected, but it does not establish lupus by itself. Healthy people and individuals with infections, other illnesses or certain medication exposures may also have a positive ANA.
Yes. ESR and CRP may be normal in some autoimmune conditions or during periods of lower disease activity. Normal inflammatory markers do not exclude every autoimmune disease.
Yes. Autoimmune diseases can cluster because they may share genetic and immune-regulatory factors. New symptoms still require appropriate evaluation rather than being automatically attributed to another autoimmune diagnosis.
No. AIP may be used as a structured, temporary elimination and reintroduction strategy for selected people. It is not required for everyone and should not become an indefinite restricted diet without evaluating adequacy, response and food reintroduction.
Not automatically. Nutrition, sleep, movement and stress support can meaningfully improve health, but medication may be necessary to control inflammation, protect organs or replace lost hormone production. Treatment changes belong with the prescribing clinician.
Kumar P, Yip J, Wang A, Marty T, Fathman CG. Autoimmune Disease: Genetic Susceptibility, Environmental Triggers, and Immune Dysregulation. Where Can We Develop Therapies? 2025. PMID: 40852720.
Aggarwal A. Role of Autoantibody Testing. Best Pract Res Clin Rheumatol. 2014;28(6):907–920. PMID: 26096093.
Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease. 2021. PMID: 33668697.
Seronegative Autoimmune Diseases: A Challenging Diagnosis. Autoimmun Rev. 2022. PMID: 35840037.
Understanding Sex Differences in Autoimmune Diseases: Immunologic Mechanisms. 2025. PMID: 40806232.
More X’s, More Problems: How Contributions From the X Chromosomes Enhance Female Predisposition for Autoimmunity. 2025. PMID: 40020257.
Song H, Fang F, Tomasson G, et al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 2018;319(23):2388–2400. PMID: 29922828.
Bjornevik K, Cortese M, Healy BC, et al. Longitudinal Analysis Reveals High Prevalence of Epstein–Barr Virus Associated With Multiple Sclerosis. Science. 2022;375(6578):296–301. PMID: 35025605.
Association Between Occupational and Environmental Dust Exposure and Autoimmune Diseases: A Systematic Review and Meta-Analysis. 2025. PMID: 40418862.
Xu Y, Xu J, Li S, et al. Association Between Environmental Endocrine Disruptors and Autoimmune Diseases: A Systematic Review and Meta-Analysis. iScience. 2025;28(11):113822. PMID: 41280698.
Vitamin, Antioxidant and Micronutrient Supplementation and the Risk of Developing Incident Autoimmune Diseases: A Systematic Review and Meta-Analysis. 2024. PMID: 39717776.
Is a Functional Cure Possible in Autoimmune Diseases? Evidence From Trigger Eradication, Transplantation, and Cellular Therapies. 2025. PMID: 41436900.